-
1
-
-
79955783988
-
Nutrients, food groups, dietary patterns, and risk of pancreatic cancer in postmenopausal women
-
Inoue-Choi M, Flood A, Robien K, et al. Nutrients, food groups, dietary patterns, and risk of pancreatic cancer in postmenopausal women. Cancer Epidemiol Biomarkers Prev. 2011;20:711-714.
-
(2011)
Cancer Epidemiol Biomarkers Prev
, vol.20
, pp. 711-714
-
-
Inoue-Choi, M.1
Flood, A.2
Robien, K.3
-
2
-
-
34247473918
-
Dietary mutagen exposure and risk of pancreatic cancer
-
DOI 10.1158/1055-9965.EPI-06-0993
-
Li D, Day RS, Bondy ML, et al. Dietary mutagen exposure and risk of pancreatic cancer. Cancer Epidemiol Biomarkers Prev. 2007;16:655-661. (Pubitemid 46650565)
-
(2007)
Cancer Epidemiology Biomarkers and Prevention
, vol.16
, Issue.4
, pp. 655-661
-
-
Li, D.1
Day, R.S.2
Bondy, M.L.3
Sinha, R.4
Nguyen, N.T.5
Evans, D.B.6
Abbruzzese, J.L.7
Hassan, M.M.8
-
3
-
-
12144287320
-
A Randomized Trial of Chemoradiotherapy and Chemotherapy after Resection of Pancreatic Cancer
-
DOI 10.1056/NEJMoa032295
-
Neoptolemos JP, Stocken DD, Friess H, et al. A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med. 2004;350:1200-1210. (Pubitemid 38339364)
-
(2004)
New England Journal of Medicine
, vol.350
, Issue.12
, pp. 1200-1210
-
-
Neoptolemos, J.P.1
Stocken, D.D.2
Friess, H.3
Bassi, C.4
Dunn, J.A.5
Hickey, H.6
Beger, H.7
Fernandez-Cruz, L.8
Dervenis, C.9
Lacaine, F.10
Falconi, M.11
Pederzoli, P.12
Pap, A.13
Spooner, D.14
Kerr, D.J.15
Buchler, M.W.16
-
4
-
-
77955635233
-
Cancer statistics, 2010
-
Jemal A, Siegel R, Xu J, et al. Cancer statistics, 2010. CA Cancer J Clin. 2010;60:277-300.
-
(2010)
CA Cancer J Clin.
, vol.60
, pp. 277-300
-
-
Jemal, A.1
Siegel, R.2
Xu, J.3
-
5
-
-
21444450527
-
Low-dose aspirin in the primary prevention of cancer. The women's health study: A randomized controlled trial
-
DOI 10.1001/jama.294.1.47
-
Cook NR, Lee IM, Gaziano JM, et al. Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial. JAMA. 2005;294:47-55. (Pubitemid 41002838)
-
(2005)
Journal of the American Medical Association
, vol.294
, Issue.1
, pp. 47-55
-
-
Cook, N.R.1
Lee, I.-M.2
Gaziano, J.M.3
Gordon, D.4
Ridker, P.M.5
Manson, J.E.6
Hennekens, C.H.7
Buring, J.E.8
-
6
-
-
34248157118
-
Effect of aspirin on long-term risk of colorectal cancer: Consistent evidence from randomised and observational studies
-
DOI 10.1016/S0140-6736(07)60747-8, PII S0140673607607478
-
Flossmann E, Rothwell PM. Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies. Lancet. 2007;369:1603-1613. (Pubitemid 46710123)
-
(2007)
Lancet
, vol.369
, Issue.9573
, pp. 1603-1613
-
-
Flossmann, E.1
Rothwell, P.M.2
-
7
-
-
78650825618
-
Effect of daily aspirin on long-term risk of death due to cancer: Analysis of individual patient data from randomised trials
-
Rothwell PM, Fowkes FG, Belch JF, et al. Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials. Lancet. 2011;377:31-41.
-
(2011)
Lancet
, vol.377
, pp. 31-41
-
-
Rothwell, P.M.1
Fowkes, F.G.2
Belch, J.F.3
-
8
-
-
77953538362
-
Meta-analysis on the relationship between nonsteroidal anti-inflammatory drug use and gastric cancer
-
Tian W, Zhao Y, Liu S, et al. Meta-analysis on the relationship between nonsteroidal anti-inflammatory drug use and gastric cancer. Eur J Cancer Prev. 2010;19:288-298.
-
(2010)
Eur J Cancer Prev
, vol.19
, pp. 288-298
-
-
Tian, W.1
Zhao, Y.2
Liu, S.3
-
9
-
-
36148978529
-
Cyclooxygenases, prostanoids, and tumor progression
-
DOI 10.1007/s10555-007-9096-5, Forty Years of Metastasis Research: A Tribute to Dr. Isaiah J. Fidler
-
Wang MT, Honn KV, Nie D. Cyclooxygenases, prostanoids, and tumor progression. Cancer Metastasis Rev. 2007;26:525-534. (Pubitemid 350115125)
-
(2007)
Cancer and Metastasis Reviews
, vol.26
, Issue.3-4
, pp. 525-534
-
-
Wang, M.-T.1
Honn, K.V.2
Nie, D.3
-
10
-
-
33744484033
-
Mechanisms leading to COX-2 expression and COX-2 induced tumorigenesis: Topical therapeutic strategies targeting COX-2 expression and activity
-
Telliez A, Furman C, Pommery N, et al. Mechanisms leading to COX-2 expression and COX-2 induced tumorigenesis: topical therapeutic strategies targeting COX-2 expression and activity. Anticancer Agents Med Chem. 2006;6:187-208. (Pubitemid 43796638)
-
(2006)
Anti-Cancer Agents in Medicinal Chemistry
, vol.6
, Issue.3
, pp. 187-208
-
-
Telliez, A.1
Furman, C.2
Pommery, N.3
Henichart, J.-P.4
-
11
-
-
77951718562
-
Concurrent inhibition of nf-kappab, cyclooxygenase-2, and epidermal growth factor receptor leads to greater anti-tumor activity in pancreatic cancer
-
Ali S, Banerjee S, Schaffert JM, et al. Concurrent inhibition of NF-kappaB, cyclooxygenase-2, and epidermal growth factor receptor leads to greater anti-tumor activity in pancreatic cancer. J Cell Biochem. 2010;110:171-181.
-
(2010)
J Cell Biochem
, vol.110
, pp. 171-181
-
-
Ali, S.1
Banerjee, S.2
Schaffert, J.M.3
-
12
-
-
48149084823
-
Selective inhibition of cyclooxygenase-2 suppresses the growth of pancreatic cancer cells in vitro and in vivo
-
Xu XF, Xie CG, Wang XP, et al. Selective inhibition of cyclooxygenase-2 suppresses the growth of pancreatic cancer cells in vitro and in vivo. Tohoku J Exp Med. 2008;215:149-157.
-
(2008)
Tohoku J Exp Med
, vol.215
, pp. 149-157
-
-
Xu, X.F.1
Xie, C.G.2
Wang, X.P.3
-
13
-
-
1842844445
-
Aspirin use and pancreatic cancer mortality in a large United States cohort
-
Jacobs EJ, Connell CJ, Rodriguez C, et al. Aspirin use and pancreatic cancer mortality in a large United States cohort. J Natl Cancer Inst. 2004;96:524-528. (Pubitemid 38559576)
-
(2004)
Journal of the National Cancer Institute
, vol.96
, Issue.7
, pp. 524-528
-
-
Jacobs, E.J.1
Connell, C.J.2
Rodriguez, C.3
Patel, A.V.4
Calle, E.E.5
Thun, M.J.6
-
14
-
-
0037036670
-
Association between nonsteroidal anti-inflammatory drug use and the incidence of pancreatic cancer
-
Anderson KE, Johnson TW, Lazovich D, et al. Association between nonsteroidal anti-inflammatory drug use and the incidence of pancreatic cancer. J Natl Cancer Inst. 2002;94:1168-1171. (Pubitemid 34919054)
-
(2002)
Journal of the National Cancer Institute
, vol.94
, Issue.15
, pp. 1168-1171
-
-
Anderson, K.E.1
Johnson, T.W.2
Lazovich, D.3
Folsom, A.R.4
-
15
-
-
81555195411
-
Aspirin nonsteroidal anti-inflammatory drugs (nsaid) acetaminophen and pancreatic cancer risk: A clinic-based case-control study
-
Tan XL, Reid-Lombardo KM, Bamlet WR, et al. Aspirin, nonsteroidal anti-inflammatory drugs (NSAID), acetaminophen, and pancreatic cancer risk: a clinic-based case-control study. Cancer Prev Res (Phila). 2011; 4:1835-1841.
-
(2011)
Cancer Prev Res (Phila)
, vol.4
, pp. 1835-1841
-
-
Tan, X.L.1
Reid-Lombardo, K.M.2
Bamlet, W.R.3
-
16
-
-
33846023679
-
Aspirin and nonsteroidal anti-inflammatory drug use and risk of pancreatic cancer: A meta-analysis
-
DOI 10.1158/1055-9965.EPI-06-0574
-
Larsson SC, Giovannucci E, Bergkvist L, et al. Aspirin and nonsteroidal anti-inflammatory drug use and risk of pancreatic cancer: a meta-analysis. Cancer Epidemiol Biomarkers Prev. 2006;15:2561-2564. (Pubitemid 46048323)
-
(2006)
Cancer Epidemiology Biomarkers and Prevention
, vol.15
, Issue.12
, pp. 2561-2564
-
-
Larsson, S.C.1
Giovannucci, E.2
Bergkvist, L.3
Wolk, A.4
-
17
-
-
34748813750
-
Meta-analysis: The use of non-steroidal anti-inflammatory drugs and pancreatic cancer risk for different exposure categories
-
DOI 10.1111/j.1365-2036.2007.03495.x
-
Capurso G, Schunemann HJ, Terrenato I, et al. Meta-analysis: the use of non-steroidal anti-inflammatory drugs and pancreatic cancer risk for different exposure categories. Aliment Pharmacol Ther. 2007;26:1089-1099. (Pubitemid 47480965)
-
(2007)
Alimentary Pharmacology and Therapeutics
, vol.26
, Issue.8
, pp. 1089-1099
-
-
Capurso, G.1
Schunemann, H.J.2
Terrenato, I.3
Moretti, A.4
Koch, M.5
Muti, P.6
Capurso, L.7
Delle Fave, G.8
-
18
-
-
77951666450
-
Non-steroidal anti-inflammatory drugs and pancreatic cancer risk: A nested case-control study
-
Bradley MC, Hughes CM, Cantwell MM, et al. Non-steroidal anti-inflammatory drugs and pancreatic cancer risk: a nested case-control study. Br J Cancer. 2010;102:1415-1421.
-
(2010)
Br J Cancer
, vol.102
, pp. 1415-1421
-
-
Bradley, M.C.1
Hughes, C.M.2
Cantwell, M.M.3
-
20
-
-
84861722871
-
Aspirin and cancer risk: A quantitative review to 2011
-
Bosetti C, Rosato V, Gallus S, et al. Aspirin and cancer risk: a quantitative review to 2011. Ann Oncol. 2012;23:1403-1415.
-
(2012)
Ann Oncol
, vol.23
, pp. 1403-1415
-
-
Bosetti, C.1
Rosato, V.2
Gallus, S.3
-
21
-
-
0023484789
-
Quantitative methods in the review of epidemiologic literature
-
Greenland S. Quantitative methods in the review of epidemiologic literature. Epidemiol Rev. 1987;9:1-30.
-
(1987)
Epidemiol Rev
, vol.9
, pp. 1-30
-
-
Greenland, S.1
-
22
-
-
33845571913
-
Random-effects model for meta-analysis of clinical trials: An update
-
DOI 10.1016/j.cct.2006.04.004, PII S1551714406000486
-
DerSimonian R, Kacker R. Random-effects model for meta-analysis of clinical trials: an update. Contemp Clin Trials. 2007;28:105-114. (Pubitemid 44937874)
-
(2007)
Contemporary Clinical Trials
, vol.28
, Issue.2
, pp. 105-114
-
-
DerSimonian, R.1
Kacker, R.2
-
23
-
-
0037098199
-
Quantifying heterogeneity in a meta-analysis
-
DOI 10.1002/sim.1186
-
Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539-1558. (Pubitemid 34746062)
-
(2002)
Statistics in Medicine
, vol.21
, Issue.11
, pp. 1539-1558
-
-
Higgins, J.P.T.1
Thompson, S.G.2
-
24
-
-
0030922816
-
Bias in meta-analysis detected by a simple, graphical test
-
Egger M, Davey Smith G, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629-634. (Pubitemid 27387172)
-
(1997)
British Medical Journal
, vol.315
, Issue.7109
, pp. 629-634
-
-
Egger, M.1
Smith, G.D.2
Schneider, M.3
Minder, C.4
-
26
-
-
0037430059
-
A population-based cohort study of the risk of colorectal and other cancers among users of low-dose aspirin
-
DOI 10.1038/sj.bjc.6600760
-
Friis S, Sorensen HT, McLaughlin JK, et al. A population-based cohort study of the risk of colorectal and other cancers among users of low-dose aspirin. Br J Cancer. 2003;88:684-688. (Pubitemid 36411444)
-
(2003)
British Journal of Cancer
, vol.88
, Issue.5
, pp. 684-688
-
-
Friis, S.1
Sorensen, H.T.2
McLaughlin, J.K.3
Johnsen, S.P.4
Blot, W.J.5
Olsen, J.H.6
-
27
-
-
6344280568
-
Aspirin use and mortality from cancer in a prospective cohort study
-
Ratnasinghe LD, Graubard BI, Kahle L, et al. Aspirin use and mortality from cancer in a prospective cohort study. Anticancer Res. 2004;24:3177-3184. (Pubitemid 39390970)
-
(2004)
Anticancer Research
, vol.24
, Issue.5
, pp. 3177-3184
-
-
Ratnasinghe, L.D.1
Graubard, B.I.2
Kahle, L.3
Tangrea, J.A.4
Taylor, P.R.5
Hawk, E.6
-
28
-
-
0842280764
-
A prospective study of aspirin use and the risk of pancreatic cancer in women
-
Schernhammer ES, Kang JH, Chan AT, et al. A prospective study of aspirin use and the risk of pancreatic cancer in women. J Natl Cancer Inst. 2004;96:22-28. (Pubitemid 38180956)
-
(2004)
Journal of the National Cancer Institute
, vol.96
, Issue.1
, pp. 22-28
-
-
Schernhammer, E.S.1
Kang, J.-H.2
Chan, A.T.3
Michaud, D.S.4
Skinner, H.G.5
Giovannucci, E.6
Colditz, G.A.7
Fuchs, C.S.8
-
30
-
-
67949089533
-
Aspirin induces apoptosis through the blockade of il-6-stat3 signaling pathway in human glioblastoma a172 cells
-
Kim SR, Bae MK, Kim JY, et al. Aspirin induces apoptosis through the blockade of IL-6-STAT3 signaling pathway in human glioblastoma A172 cells. Biochem Biophys Res Commun. 2009;387:342-347.
-
(2009)
Biochem Biophys Res Commun
, vol.387
, pp. 342-347
-
-
Kim, S.R.1
Bae, M.K.2
Kim, J.Y.3
-
31
-
-
77953319891
-
Cox-2 as a target for cancer chemotherapy
-
Ghosh N, Chaki R, Mandal V, et al. COX-2 as a target for cancer chemotherapy. Pharmacol Rep. 2010;62:233-244.
-
(2010)
Pharmacol Rep
, vol.62
, pp. 233-244
-
-
Ghosh, N.1
Chaki, R.2
Mandal, V.3
-
32
-
-
20444365468
-
Nuclear factor kappa B activation is a potential target for preventing pancreatic carcinoma by aspirin
-
DOI 10.1002/cncr.21075
-
Sclabas GM, Uwagawa T, Schmidt C, et al. Nuclear factor kappa B activation is a potential target for preventing pancreatic carcinoma by aspirin. Cancer. 2005;103:2485-2490. (Pubitemid 40800526)
-
(2005)
Cancer
, vol.103
, Issue.12
, pp. 2485-2490
-
-
Sclabas, G.M.1
Uwagawa, T.2
Schmidt, C.3
Hess, K.R.4
Evans, D.B.5
Abbruzzese, J.L.6
Chiao, P.J.7
-
33
-
-
60749128400
-
Aspirin for the chemoprevention of colorectal adenomas: Meta-analysis of the randomized trials
-
Cole BF, Logan RF, Halabi S, et al. Aspirin for the chemoprevention of colorectal adenomas: meta-analysis of the randomized trials. J Natl Cancer Inst. 2009;101:256-266.
-
(2009)
J Natl Cancer Inst
, vol.101
, pp. 256-266
-
-
Cole, B.F.1
Logan, R.F.2
Halabi, S.3
-
34
-
-
0026777701
-
Methods for trend estimation from summarized dose-response data, with applications to meta-analysis
-
Greenland S, Longnecker MP. Methods for trend estimation from summarized dose-response data, with applications to meta-analysis. Am J Epidemiol. 1992;135:1301-1309.
-
(1992)
Am J Epidemiol
, vol.135
, pp. 1301-1309
-
-
Greenland, S.1
Longnecker, M.P.2
-
35
-
-
33646496189
-
Generalized least squares for trend estimation of summarized dose-response data
-
Orsini N, Bellocco R. Generalized least squares for trend estimation of summarized dose-response data. Stata J. 2006;6:40-57. (Pubitemid 43708443)
-
(2006)
Stata Journal
, vol.6
, Issue.1
, pp. 40-57
-
-
Orsini, N.1
Bellocco, R.2
Greenland, S.3
-
36
-
-
78650215449
-
Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials
-
Rothwell PM,Wilson M, Elwin CE, et al. Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials. Lancet. 2010;376:1741-1750.
-
(2010)
Lancet
, vol.376
, pp. 1741-1750
-
-
Rothwell, P.M.1
Wilson, M.2
Elwin, C.E.3
-
37
-
-
69349099139
-
Publication bias in clinical trials due to statistical significance or direction of trial results
-
Hopewell S, Loudon K, Clarke MJ, et al. Publication bias in clinical trials due to statistical significance or direction of trial results. Cochrane Database Syst Rev. 2009;MR000006.
-
(2009)
Cochrane Database Syst Rev
-
-
Hopewell, S.1
Loudon, K.2
Clarke, M.J.3
|